Celixir cleared to start trial of stem cell therapy for heart failure – PMLiVE
PMLiVE |
Celixir cleared to start trial of stem cell therapy for heart failure
PMLiVE UK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel – its stem cell-based therapy for heart failure – that could potentially support approval. Heartcel is a preparation of off-the-shelf immunomodulatory progenitor … |
